Unilever Shares Fall Despite Strong Sales and Upgraded Targets

2026-10-28 companies

London, Wednesday, 28 October 2026.
Despite beating quarterly forecasts and raising full-year volume targets, Unilever shares dropped over 1% as a 0.9% sales decline in developed markets fueled persistent investor concerns.

Unilever’s Strong Quarter Meets Skeptical Market

On Wednesday, 28 October 2026, Unilever PLC (LON: ULVR, NYSE: UL) reported third-quarter 2026 revenue of €13.27 billion, beating consensus estimates of €13.09 billion, representing a 1.375% [alert! ‘using total turnover figures from Unilever’s Q3 2026 results and consensus estimates from MarketScreener’] [1][6]. Organic sales growth of 5.2% exceeded the 4.8% forecast, driven by underlying volume growth of 2.9% and price increases of 2.3% [1][5][6]. This performance was led by double-digit growth in Home Care (9.1%) and Personal Care (6.3%), while the Foods division lagged with just 0.1% growth [1][5][6]. Despite these positive metrics, the company’s shares declined approximately 1.5% during London trading, extending a four-session losing streak [1][2][5].

Upgraded Guidance Fails to Convince Investors

Unilever slightly raised its full-year 2026 outlook, now targeting at least 3% underlying volume growth (previously ~3%) and organic sales growth of around 5% in the second half, while maintaining guidance of 4%-6% for the full year [1][6]. The company also expects a modest improvement in underlying operating margins from the 20.0% recorded in 2025 [1][6]. However, analysts at Jefferies reiterated an ‘Underperform’ rating with a GBX 4,000 price target, citing potential downside of 82300% [alert! ‘using Unilever’s closing price and Jefferies’ target price’] [4]. This skepticism reflects broader concerns about consumer demand elasticity and pricing power in developed markets, where sales declined 0.9% in Q3 [1][6].

Regional Disparities Highlight Structural Challenges

The divergence between emerging and developed markets remained stark in Q3 2026. Emerging markets delivered 9.5% organic sales growth, driven by India (+15%) and Indonesia (+7%), while developed markets contracted by 0.9%, with Europe posting a 1% decline [alert! ‘using Q3 2026 regional USG metrics from Unilever’s full announcement’] [6]. This trend underscores the structural challenges facing Unilever in mature economies, where higher commodity costs and competitive pressures are squeezing margins [1][2][6]. The underperformance in developed markets was particularly pronounced in the Foods division, which grew just 0.1% versus the 1.3% expected by analysts [1][2][5].

Analyst Divergence and Board Changes Add to Uncertainty

Analyst opinions on Unilever remain sharply divided. While Jefferies maintained an ‘Underperform’ rating, UBS cut its target to GBp 4,390 with a ‘Sell’ rating, whereas Bernstein maintained a ‘Buy’ rating with a GBp 5,800 target [3][4]. This divergence highlights the market’s uncertainty about Unilever’s ability to sustain growth amid shifting consumer behaviors and margin pressures [3][4]. Adding to the governance concerns, board member Ruby Lu resigned on 24 October 2026, altering the company’s leadership dynamics [3]. With an Investor Event scheduled for 4 November 2026 to outline Unilever’s transformation strategy, the coming weeks will be critical in determining whether management can regain investor confidence [6].

Sources

Consumer goods Unilever